Cargando…
iPS cell-based therapy for Parkinson's disease: A Kyoto trial
Following intensive efforts since their discovery little more than 10 years ago, cell replacement therapy using induced pluripotent stem (iPS) cells is now becoming reality. However, there remain several obstacles in the translation of basic research to clinical application, obstacles known as the “...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Japanese Society for Regenerative Medicine
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794047/ https://www.ncbi.nlm.nih.gov/pubmed/33490319 http://dx.doi.org/10.1016/j.reth.2020.06.002 |